A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients The purpose of the study was to assess the clinical effect of QAW039 in non-atopic asthmatics taking low dose Inhaled Corticosteroid (ICS) as background therapy.

• Pays Belgium, Colombia, Czech Republic, Germany, India, Korea, Republic of, Poland, Romania, South Africa, United States
• Organes Aucun
• Spécialités Aucune

Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic ...

• Pays Germany, Hungary, Lithuania, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Ukraine, Australia, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia
• Organes Aucun
• Spécialités Aucune

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II) Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that binds PCSK9 (proprotein convertase subtilisin/kexin type 9). Primary Objective of the study: To demonstrate...

• Pays Canada, Denmark, France, Hungary, Israel, Korea, Republic of, Russian Federation, South Africa, Ukraine, United States
• Organes Aucun
• Spécialités Aucune

A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis Identify effective doses of cetrorelix SR in the treatment of symptoms of endometriosis, describe dose effect relationship and duration of symptom relief

• Pays Australia, Belgium, Bulgaria, Germany, Romania, Russian Federation, South Africa, Ukraine
• Organes Aucun
• Spécialités Aucune

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) The purpose of the run-in phase of this study is to determine the appropriate and tolerable dose of ZD6474 (200mg or 300mg) to be administered in combination with paclitaxel and carboplati...

• Pays Finland, France, Germany, India, Italy, South Africa, Spain, Thailand, United States
• Organes Aucun
• Spécialités Aucune

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease To evaluate the long-term maintenance of response, safety and tolerability of repeated administration of adalimumab in subjects with Crohn's disease who participated in and successfully co...

• Pays Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain, Sweden, United Kingdom, United States
• Organes Aucun
• Spécialités Aucune

Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region This study will assess the safety and immunogenicity of a GSK Biologicals' candidate TB vaccine administered at 0, 1 months to healthy adults living in a TB-endemic region. The Protocol Po...

• Pays South Africa
• Organes Aucun
• Spécialités Aucune

High dose amphotericin B with flucytosine, and amphotericin B plus high dose fluconazole for treatment of cryptococcal meningitis in human immunodeficiency (HIV)-infected patients Not provided at time of registration

• Pays South Africa, Thailand
• Organes Aucun
• Spécialités Aucune

Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

• Pays Belgium, Czech Republic, France, Netherlands, Poland, South Africa
• Organes Aucun
• Spécialités Aucune

ORBIT study

• Pays South Africa
• Organes Aucun
• Spécialités Aucune